Revision Year: 2020 Publisher: LABORATOIRE INNOTECH INTERNATIONAL, 22 AVENUE ARISTIDE BRIAND, 94110 ARCUEIL
POLYGYNAX, vaginal capsule.
| Pharmaceutical Form |
|---|
|
Vaginal capsule. |
Neomycin sulfate 35 000 I.U.
Polymyxin B sulfate 35 000 I.U.
Nystatin 100 000 I.U.
For one vaginal capsule.
Excipient with known effect: Hydrogenated soybean oil.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Neomycin |
Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. |
|
| Nystatin |
Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans. |
|
| Polymyxin B |
Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane. |
| List of Excipients |
|---|
|
PEG-6 stearate and glycol stearate and PEG-32 stearate (Tefose 63), hydrogenated soybean oil, dimeticone 1000. Composition of the shell soft capsule: gelatine, glycerol, dimeticone 1000. |
Box of 1 or 2 blisters (PVC/PVDC/Aluminium) of 6 capsules.
Not all pack sizes may be marketed.
LABORATOIRE INNOTECH INTERNATIONAL, 22 AVENUE ARISTIDE BRIAND, 94110 ARCUEIL
MA093/00401
02nd January 2007 / 22nd November 2018
| Drug | Countries | |
|---|---|---|
| POLYGYNAX | Cyprus, Ecuador, Estonia, France, Hong Kong, Croatia, Lithuania, Malta, Mexico, Nigeria, Romania, Singapore, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
